RenovaCare Announces Termination of StemCell Systems R&D Agreement May 3, 2022 10:06AM
RenovaCare Announces Management Changes Mar 24, 2022 08:30AM
RenovaCare Provides Clinical and Corporate Update Mar 9, 2022 03:35PM
RenovaCare Establishes Leadership Position in Cell Isolation and Spray Technology with Newly Awarded U.S. Patent Oct 14, 2021 08:30AM
RenovaCare Provides Update on Clinical Trial for the SkinGun™ and CellMist™ System for Wound Healing Jul 22, 2021 08:30AM
View Older Stories

Jun 7, 2021 08:30AM RenovaCare Clinical Trial to Start at U.S. Burn Centers
Jun 1, 2021 08:30AM RenovaCare Responds to SEC Complaint
May 6, 2021 08:30AM FDA Grants RenovaCare Full IDE Approval for Safety and Feasibility Clinical Trial
Mar 30, 2021 08:30AM RenovaCare Announces Organizational Changes and Appointment of New Officers
Feb 25, 2021 08:30AM RenovaCare to Present at H.C. Wainwright Global Life Sciences Conference March 9-10, 2021
Jan 19, 2021 08:30AM RenovaCare to Present at Noble Capital Markets Annual Investor Conference on January 19, 2021
Jan 8, 2021 08:30AM RenovaCare to Present at H.C. Wainwright BioConnect 2021 Conference
Dec 22, 2020 08:00AM RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook
Nov 19, 2020 08:15AM RenovaCare Awarded New Patents Allowing Greater Versatility of SkinGun™; Sterility in Field Environments; Spray Solutions to Now Include Targeted Cells, Drugs or Hormones
Oct 22, 2020 04:35PM RenovaCare to Commence Investor Business and Financial Presentations; Webcast on October 29, 2020
Oct 5, 2020 04:28PM RenovaCare Elects Alan L. Rubino to Chairman of the Board of Directors
Sep 15, 2020 08:30AM RenovaCare to Present at BioNJ/JP Morgan/J&J BioPartnering Conference
Aug 11, 2020 08:30AM RenovaCare Receives FDA Conditional IDE Approval of CellMist™ System and SkinGun™ Device, Enabling Clinical Study for Safety and Feasibility
Aug 4, 2020 08:30AM RenovaCare Appoints Dr. Lydia M. Evans to Its Board of Directors and Increases Board Membership
Jul 1, 2020 08:30AM RenovaCare Launches R&D Innovation Center (Berlin) for Organ & Tissue Regeneration
Jun 16, 2020 08:30AM Mr. Robert W. Cook, Seasoned Biotech Executive, Joins RenovaCare as Chief Financial Officer and Board Secretary
Jun 10, 2020 08:36AM RenovaCare Appoints Chief Medical Officer, Dr. Jo Ellen Schweinle, Former Sr. Medical Officer at U.S. Dept. of Health and Human Services
May 28, 2020 08:30AM RenovaCare Strengthens FDA Program with Leading U.S. Regulatory Group and Significant Investment
May 26, 2020 08:30AM RenovaCare Appoints Founding Director of BARDA Dr. Robin A. Robinson to Chief Scientific Officer
Mar 30, 2020 08:32AM Spray-On Gene Therapy With RenovaCare SkinGun™ in New Study Underway at King’s College London
Mar 11, 2020 08:30AM RenovaCare Announces New Corporate Headquarters and Laboratory Facilities
Dec 5, 2019 08:30AM RenovaCare Stockholder Update and 2020 Outlook from the CEO
Nov 26, 2019 08:30AM Dr. Emanual Maverakis, Recipient of Presidential Award for Scientists and Engineers, Joins RenovaCare
Nov 18, 2019 08:30AM RenovaCare Appoints Alan L. Rubino as President and CEO
Sep 24, 2019 08:30AM Dr. Frank Gerberick, Procter & Gamble Product Safety Veteran, Joins RenovaCare
Aug 20, 2019 08:30AM Dr. Robin Robinson, Founding Director of BARDA Joins RenovaCare
Aug 14, 2019 08:30AM RenovaCare Awarded New Patent Allowing for the Spray of Stem Cells for Regeneration of Organs and Tissues
Jul 11, 2019 08:30AM Former Johnson & Johnson Worldwide Director for Advanced Wound Care Joins RenovaCare
Jun 27, 2019 08:38AM RenovaCare Appoints VP to Expand and Accelerate Intellectual Property and Licensing
Jun 6, 2019 08:30AM Vice President to Expand RenovaCare SkinGun™ Technology for New Medical Conditions Beyond Burns
Nov 29, 2018 08:30AM RenovaCare Chairman Invests $15.5 Million to Fund SkinGun™ Regulatory Submissions and Clinical Trials
Oct 26, 2018 08:30AM Mr. Steve Yan-Klassen Appointed as Chief Financial Officer
Mar 21, 2018 08:30AM RenovaCare Board of Directors Elects Majority Stockholder Harmel S. Rayat as Chairman
Mar 5, 2018 08:30AM RenovaCare Takes Action to Protect Shareholder Interests
Feb 26, 2018 10:54AM RenovaCare Issues Important Shareholder Update Following Patent Win and FDA News
Feb 21, 2018 08:30AM RenovaCare Secures Patent Victory and Continues to Bolster IP Portfolio
Feb 15, 2018 08:30AM RenovaCare Announces Successful FDA Meeting
Feb 12, 2018 04:22PM RenovaCare Issues Stern Response to Admitted Short-Seller, Streetsweeper, Affiliated with Felon Convicted of Securities Fraud
Jan 30, 2018 08:00AM RenovaCare Highlights Clinical Results From 44 Severe Burn Patients Published in Medical Journal
Jan 9, 2018 08:30AM RenovaCare 2018 Outlook and Shareholder Update from the CEO
Jan 8, 2018 03:45PM RenovaCare Comments on Recent Market Activity
Oct 31, 2017 09:00AM RenovaCare SkinGun™ Stem Cell Sprayer on Exhibit at the Science Museum in London
Oct 20, 2017 10:00AM RenovaCare Announces Successful Closing of Financing
Oct 17, 2017 05:29PM RenovaCare, Inc. Closes Registered Direct Offering and Concurrent Private Placement
Jul 11, 2017 09:15AM Peer-Reviewed Publication Validates RenovaCare Approach to Rapidly-Processing Stem Cells for Burns and Wounds
Apr 27, 2017 09:15AM Outcomes of Burn Patients Treated with Cell Spray Technology Behind RenovaCare SkinGun™ Published in Prestigious Medical Journal
Jan 17, 2017 09:15AM RenovaCare: 2017 Shareholder Update
Dec 6, 2016 09:15AM RenovaCare Awarded U.S. Patent For SkinGun™ Device To Spray Stem Cells On To Wounds
May 31, 2016 09:15AM Latest Test Results Bolster RenovaCare Strategy to Spray Stem Cells on Wounds and Burns for Rapid Healing
May 3, 2016 09:15AM New Study: RenovaCare SkinGun™ Ultra-Gently Sprays Human Stem Cells to Achieve ‘Gold-Standard’ Viability for Skin Regeneration
View Older Stories